[1]
|
Drug–drug interactions involving classic psychedelics: A systematic review
Journal of Psychopharmacology,
2024
DOI:10.1177/02698811231211219
|
|
|
[2]
|
Phytochemical screening and effect of Viscum album L. on monoamine oxidase A and B activity and serotonin, dopamine and serotonin receptor 5-HTR1A levels in Galleria mellonealla (Lepidoptera)
Journal of Ethnopharmacology,
2022
DOI:10.1016/j.jep.2022.115604
|
|
|
[3]
|
A review of monoamine oxidase (MAO) inhibitors in tobacco or tobacco smoke
NeuroToxicology,
2022
DOI:10.1016/j.neuro.2022.09.008
|
|
|
[4]
|
Insights into the Mechanism of the Therapeutic Potential of Herbal
Monoamine Oxidase Inhibitors in Neurological Diseases
Current Drug Targets,
2022
DOI:10.2174/1389450122666210707120256
|
|
|
[5]
|
Phytochemical screening and effect of Viscum album L. on monoamine oxidase A and B activity and serotonin, dopamine and serotonin receptor 5-HTR1A levels in Galleria mellonealla (Lepidoptera)
Journal of Ethnopharmacology,
2022
DOI:10.1016/j.jep.2022.115604
|
|
|
[6]
|
Drug reprofiling history and potential therapies against Parkinson’s disease
Frontiers in Pharmacology,
2022
DOI:10.3389/fphar.2022.1028356
|
|
|
[7]
|
In silico study to identify new monoamine oxidase type a (MAO-A) selective inhibitors from natural source by virtual screening and molecular dynamics simulation
Journal of Molecular Structure,
2022
DOI:10.1016/j.molstruc.2021.132244
|
|
|
[8]
|
A review of monoamine oxidase (MAO) inhibitors in tobacco or tobacco smoke
NeuroToxicology,
2022
DOI:10.1016/j.neuro.2022.09.008
|
|
|
[9]
|
NeuroPsychopharmacotherapy
2022
DOI:10.1007/978-3-030-62059-2_98
|
|
|
[10]
|
A review of monoamine oxidase (MAO) inhibitors in tobacco or tobacco smoke
NeuroToxicology,
2022
DOI:10.1016/j.neuro.2022.09.008
|
|
|
[11]
|
In silico study to identify new monoamine oxidase type a (MAO-A) selective inhibitors from natural source by virtual screening and molecular dynamics simulation
Journal of Molecular Structure,
2022
DOI:10.1016/j.molstruc.2021.132244
|
|
|
[12]
|
NATURAL PLANT REMEDIES FOR DEPRESSION DURING THE COVID-19 PANDEMIC, UPDATE REVIEW
International Journal of Applied Pharmaceutics,
2022
DOI:10.22159/ijap.2022.v14s5.18
|
|
|
[13]
|
Review of pharmacological treatment of depression in patients with primary brain tumour and proposal of modification in management strategy
Clinical Neurology and Neurosurgery,
2022
DOI:10.1016/j.clineuro.2022.107213
|
|
|
[14]
|
Role of serendipity in the discovery of classical antidepressant drugs: Applying operational criteria and patterns of discovery
World Journal of Psychiatry,
2022
DOI:10.5498/wjp.v12.i4.588
|
|
|
[15]
|
Review of pharmacological treatment of depression in patients with primary brain tumour and proposal of modification in management strategy
Clinical Neurology and Neurosurgery,
2022
DOI:10.1016/j.clineuro.2022.107213
|
|
|
[16]
|
Development of a Novel Class of Pyridazinone Derivatives as Selective MAO-B Inhibitors
Molecules,
2022
DOI:10.3390/molecules27123801
|
|
|
[17]
|
Roles of selected non-P450 human oxidoreductase enzymes in protective and toxic effects of chemicals: review and compilation of reactions
Archives of Toxicology,
2022
DOI:10.1007/s00204-022-03304-3
|
|
|
[18]
|
Modeling the Bioactivation and Subsequent Reactivity of Drugs
Chemical Research in Toxicology,
2021
DOI:10.1021/acs.chemrestox.0c00417
|
|
|
[19]
|
Antidepressant-like effect of dehydrozingerone from Zingiber officinale by elevating monoamines in brain: in silico and in vivo studies
Pharmacological Reports,
2021
DOI:10.1007/s43440-021-00252-0
|
|
|
[20]
|
The trace amine theory of spontaneous hypertension as induced by classic monoamine oxidase inhibitors
Journal of Neural Transmission,
2021
DOI:10.1007/s00702-021-02399-9
|
|
|
[21]
|
Accelerating the identification of subtype selective inhibitors via Three-Dimensional Biologically Relevant Spectrum (BRS-3D): The monoamine oxidase subtypes as a case study
Bioorganic Chemistry,
2021
DOI:10.1016/j.bioorg.2020.104503
|
|
|
[22]
|
NeuroPsychopharmacotherapy
2021
DOI:10.1007/978-3-319-56015-1_98-1
|
|
|
[23]
|
NeuroPsychopharmacotherapy
2021
DOI:10.1007/978-3-319-56015-1_98-1
|
|
|
[24]
|
Antidepressant drugs as emerging contaminants: Occurrence in urban and non-urban waters and analytical methods for their detection
Science of The Total Environment,
2021
DOI:10.1016/j.scitotenv.2020.143722
|
|
|
[25]
|
Modeling the Bioactivation and Subsequent Reactivity of Drugs
Chemical Research in Toxicology,
2021
DOI:10.1021/acs.chemrestox.0c00417
|
|
|
[26]
|
Antidepressant drugs as emerging contaminants: Occurrence in urban and non-urban waters and analytical methods for their detection
Science of The Total Environment,
2021
DOI:10.1016/j.scitotenv.2020.143722
|
|
|
[27]
|
Morphological landscape of endothelial cell networks reveals a functional role of glutamate receptors in angiogenesis
Scientific Reports,
2020
DOI:10.1038/s41598-020-70440-0
|
|
|
[28]
|
Morphological landscape of endothelial cell networks reveals a functional role of glutamate receptors in angiogenesis
Scientific Reports,
2020
DOI:10.1038/s41598-020-70440-0
|
|
|
[29]
|
Depression and its Dilemma
IP Journal of Surgery and Allied Sciences,
2020
DOI:10.18231/j.jsas.2020.013
|
|
|
[30]
|
Morpholine as ubiquitous pharmacophore in medicinal chemistry: Deep insight into the structure-activity relationship (SAR)
Bioorganic Chemistry,
2020
DOI:10.1016/j.bioorg.2020.103578
|
|
|
[31]
|
Review on Preclinical and Clinical Evidence of Food (Beverages, Fruits and Vegetables) and Drug Interactions: Mechanism and Safety
Current Drug Therapy,
2020
DOI:10.2174/1574885514666190126141424
|
|
|
[32]
|
Synthesis, molecular modelling and biological activity of some pyridazinone derivatives as selective human monoamine oxidase-B inhibitors
Pharmacological Reports,
2020
DOI:10.1007/s43440-020-00070-w
|
|
|
[33]
|
Marine natural products with monoamine oxidase (MAO) inhibitory activity
Pharmaceutical Biology,
2020
DOI:10.1080/13880209.2020.1790618
|
|
|
[34]
|
Identification of novel monoamine oxidase selective inhibitors employing a hierarchical ligand-based virtual screening strategy
Future Medicinal Chemistry,
2019
DOI:10.4155/fmc-2018-0596
|
|
|
[35]
|
Monoamine oxidase-B inhibitors as potential neurotherapeutic agents: An overview and update
Medicinal Research Reviews,
2019
DOI:10.1002/med.21561
|
|
|
[36]
|
Attenuation of Ischemic Stroke-Caused Brain Injury by a Monoamine Oxidase Inhibitor Involves Improved Proteostasis and Reduced Neuroinflammation
Molecular Neurobiology,
2019
DOI:10.1007/s12035-019-01788-2
|
|
|
[37]
|
Novel C7-Substituted Coumarins as Selective Monoamine Oxidase Inhibitors: Discovery, Synthesis and Theoretical Simulation
Molecules,
2019
DOI:10.3390/molecules24214003
|
|
|
[38]
|
Monoamine oxidase‐B inhibitors as potential neurotherapeutic agents: An overview and update
Medicinal Research Reviews,
2019
DOI:10.1002/med.21561
|
|
|